Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
IVC > SEC Filings for IVC > Form 8-K on 21-May-2013All Recent SEC Filings

Show all filings for INVACARE CORP | Request a Trial to NEW EDGAR Online Pro

Form 8-K for INVACARE CORP


21-May-2013

Change in Directors or Principal Officers, Financial Statements and Exhibits


Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Invacare Corporation 2013 Equity Compensation Plan On May 16, 2013, Invacare Corporation (the "Company") held its Annual Meeting of Shareholders, where the Company's shareholders approved the Invacare Corporation 2013 Equity Compensation Plan (the "2013 Plan"). Under the 2013 Plan, directors and employees of the Company and its affiliates may be granted the following types of awards with respect to the Company's common shares: incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock, restricted stock units, unrestricted stock, and performance shares. The maximum number of Company common shares, without par value, available for issuance under the 2013 Plan will not exceed the sum of the following: 3,800,000 shares; plus any shares covered by an award under the 2013 Plan or the Company's recently-expired 2003 Performance Plan that are forfeited or remain unpurchased or undistributed upon termination or expiration of the award. The material terms of the 2013 Plan are summarized in the Company's definitive Proxy Statement on Schedule 14A, which was filed with the Securities and Exchange Commission on April 3, 2013.
The description of the 2013 Plan as contained herein is qualified in its entirety by reference to the full text of the 2013 Plan, a copy of which is attached hereto as Exhibit 10.1 and is incorporated herein by reference. Director Retirement
As described by the Company in its definitive Proxy Statement on Schedule 14A filed on April 3, 2013, Joseph B. Richey, II did not stand for re-election as a director at the Company's 2013 Annual Meeting of Shareholders held on May 16, 2013 in accordance with age limitations in the Company's Corporate Governance Guidelines. Accordingly, Mr. Richey's term as a director of the Company expired at the Annual Meeting and he retired as a director of the Company as of the date thereof.
Item 5.07. Submission of Matters to a Vote of Security Holders.

On May 16, 2013, the Company held its 2013 Annual Meeting of Shareholders, at which the Company's shareholders acted on proposals to: (1) elect eleven directors to a one-year term that will expire in 2014; (2) approve and adopt the Invacare Corporation 2013 Equity Compensation Plan; (3) ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the Company's 2013 fiscal year; and (4) approve, on an advisory basis, the compensation of the Company's named executive officers.


Each of the following nominees was elected for a one-year term of office expiring in 2014 with respective votes as follows:
Nominees For Withheld Broker Non-Votes Michael F. Delaney 36,930,704 1,112,026 1,501,317 C. Martin Harris, M.D. 37,001,946 1,040,784 1,501,317

A. Malachi Mixon, III  36,617,900 1,424,830    1,501,317
Gerald B. Blouch       36,702,226 1,340,504    1,501,317
William M. Weber       36,900,559 1,142,171    1,501,317
Charles S. Robb        36,997,776 1,044,954    1,501,317
Baiju R. Shah          35,403,554 2,639,176    1,501,317
James L. Jones         36,998,312 1,044,418    1,501,317
Dan T. Moore, III      36,833,945 1,208,785    1,501,317
Dale C. LaPorte        36,615,763 1,426,967    1,501,317
Ellen O. Tauscher      37,021,006 1,021,724    1,501,317

The proposal to approve and adopt the Invacare Corporation 2013 Equity Compensation Plan was approved with 34,399,865 votes for, 2,849,820 votes against, 793,045 votes abstained and 1,501,317 broker non-votes.

The proposal to ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the Company's 2013 fiscal year was approved with 39,058,459 votes for, 464,236 votes against and 21,352 votes abstained. There were no broker non-votes with respect to this proposal.

The proposal to approve, on an advisory basis, the compensation of the Company's named executive officers was approved with 36,496,209 votes for, 750,354 votes against, 796,167 votes abstained and 1,501,317 broker non-votes.



Item 9.01. Financial Statements and Exhibits.
(d) Exhibits. Exhibit No. Description
10.1 Invacare Corporation 2013 Equity Compensation Plan.


  Add IVC to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for IVC - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.